South Korea significantly reduced the lethality of coronavirus by prescribing a combination of chloroquine diphosphate salt and zinc to block COVID-19 viral enzyme.

There is no source available to support the claim that a combination of chloroquine diphosphate salt and zinc was prescribed in South Korea.

There is no source available to support the claim that a combination of chloroquine diphosphate salt and zinc was prescribed in South Korea.According to the World Health Organization, currently, there is no vaccine or a specific antiviral medicine available to prevent or treat COVID-2019. Although, many Chinese experts have suggested that Chloroquine Phosphate, an antimalarial drug, has some curative effect on the novel coronavirus disease (COVID-19) and it should be included in the next version of the treatment guidelines and applied in wider clinical trials as soon as possible. Moreover, according to the study published in PLOS Pathogens in 2010, zinc helped in blocking RNA synthesis which means that the virus was not able to replicate. By blocking replication of the virus, it slowed the virus down. Therefore, it is likely that zinc works in the same way on COVID-19, slowing down the replication of this virus. However, there is no evidence that it will actually slow down the replication process.

The first case of the coronavirus was reported in South Korea in January 2020. As of March 31, 2020, the total number of confirmed cases in South Korea stood at 9786 and on March 31, 2020, the number stood at 9661. There was an increase of 125 cases in one day and according to these figures, there is no decrease in COVID-19 cases in South Korea.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.